Purdue Pharma LP will not have its stranglehold on the OxyContin industry loosened by its patent on the drug expires next week. Usually, cheaper generic versions of a drug flood the market with competitors once a drug patent is up. However, due to the OxyContin’s potential for abuse, the FDA has said that it will not allow any versions of the generic drugs on the market. Purdue has formulated an abuse resistant form of the drug that makes it harder to crush and snort or inject.
But, Lloyd Lofton contends, people do want other things.
Life insurance has a history.
Nicolopoulos served for five years as the president of a New Hampshire agent group.
Sponsored by Orion Advisor Technology
Financial planning services help advisors differentiate themselves, improve client relationships, drive better outcomes, and more. So why don’t more advisors offer financial planning?
Sponsored by Orion Portfolio Solutions
Learn how to use seven relationship skills to attract, serve, and retain high-net-worth investors.
Don’t miss crucial news and insights you need to make informed investment advisory decisions. Join ThinkAdvisor.com now!
- Free unlimited access to ThinkAdvisor.com which provides advisors, like you, with comprehensive coverage of the products, services and trends necessary to guide your clients in making critical wealth, health and life decisions.
- Exclusive discounts on ALM and ThinkAdvisor events.
- Access to other award-winning ALM websites including TreasuryandRisk.com and Law.com.
Copyright © 2020 ALM Media Properties, LLC. All Rights Reserved.